{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:27:01Z","timestamp":1794673621516,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In a one-way cross-over study, we investigated the effect of Khat, a natural amphetamine-like psychostimulant plant, on catalytic activities of five major drug-metabolizing cytochrome P450 (CYP) enzymes. After a one-week Khat abstinence, 63 Ethiopian male volunteers were phenotyped using cocktail probe drugs (caffeine, losartan, dextromethorphan, omeprazole). Phenotyping was repeated after a one-week daily use of 400\u2009g fresh Khat leaves. Genotyping for<jats:italic>CYP1A2<\/jats:italic>,<jats:italic>CYP2C9<\/jats:italic>,<jats:italic>CYP2C19<\/jats:italic>,<jats:italic>CYP2D6<\/jats:italic>,<jats:italic>CYP3A5<\/jats:italic>were done. Urinary cathinone and phenylpropanolamine, and plasma probe drugs and metabolites concentrations were quantified using LC-MS\/MS. Effect of Khat on enzyme activities was evaluated by comparing caffeine\/paraxanthine (CYP1A2), losartan\/losartan carboxylic acid (CYP2C9), omeprazole\/5-hydroxyomeprazole (CYP2C19), dextromethorphan\/dextrorphan (CYP2D6) and dextromethorphan\/3-methoxymorphinan (CYP3A4) metabolic ratios (MR) before and after Khat use. Wilcoxon-matched-pair-test indicated a significant increase in median CYP2D6 MR (41%, p\u2009&lt;\u20090.0001), and a marginal increase in CYP3A4 and CYP2C19 MR by Khat. Repeated measure ANOVA indicated the impact of<jats:italic>CYP1A2<\/jats:italic>and<jats:italic>CYP2C19<\/jats:italic>genotype on Khat-CYP enzyme interactions. The median MR increased by 35% in<jats:italic>CYP1A2*1\/*1<\/jats:italic>(p\u2009=\u20090.07) and by 40% in carriers of defective<jats:italic>CYP2C19<\/jats:italic>alleles (p\u2009=\u20090.03). Urinary log cathinone\/phenylpropanolamine ratios significantly correlated with CYP2D6 genotype (p\u2009=\u20090.004) and CYP2D6 MR (P\u2009=\u20090.025). Khat significantly inhibits CYP2D6, marginally inhibits CYP3A4, and genotype-dependently inhibit CYP2C19 and CYP1A2 enzyme activities.<\/jats:p>","DOI":"10.1038\/s41598-018-31191-1","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T10:29:50Z","timestamp":1534760990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations"],"prefix":"10.1038","volume":"8","author":[{"given":"Worku","family":"Bedada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1076-0743","authenticated-orcid":false,"given":"Fernando","family":"de Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Engidawork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemal","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"LLerena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-0790","authenticated-orcid":false,"given":"Eleni","family":"Aklillu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"key":"31191_CR1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/bs.irn.2015.02.006","volume":"120","author":"NB Patel","year":"2015","unstructured":"Patel, N. B. \u201cNatural Amphetamine\u201d Khat: A Cultural Tradition or a Drug of Abuse? Int. Rev. Neurobiol. 120, 235\u2013255, https:\/\/doi.org\/10.1016\/bs.irn.2015.02.006 (2015).","journal-title":"Int. Rev. Neurobiol."},{"key":"31191_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/ptr.5832","volume":"31","author":"E Engidawork","year":"2017","unstructured":"Engidawork, E. Pharmacological and Toxicological Effects of Catha edulis F. (Khat). Phytotherapy research: PTR. 31, 1019\u20131028, https:\/\/doi.org\/10.1002\/ptr.5832 (2017).","journal-title":"Phytotherapy research: PTR."},{"key":"31191_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/13556210500353020","volume":"10","author":"NN Al-Hebshi","year":"2005","unstructured":"Al-Hebshi, N. N. & Skaug, N. Khat (Catha edulis)-an updated review. Addict. Biol. 10, 299\u2013307, https:\/\/doi.org\/10.1080\/13556210500353020 (2005).","journal-title":"Addict. Biol."},{"key":"31191_CR4","first-page":"11","volume":"38","author":"M Belew","year":"2000","unstructured":"Belew, M., Kebede, D., Kassaye, M. & Enquoselassie, F. The magnitude of khat use and its association with health, nutrition and socio-economic status. Ethiop. Med. J. 38, 11\u201326 (2000).","journal-title":"Ethiop. Med. J."},{"key":"31191_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00127-011-0471-8","volume":"47","author":"AD Tulloch","year":"2012","unstructured":"Tulloch, A. D., Frayn, E., Craig, T. K. & Nicholson, T. R. Khat use among Somali mental health service users in South London. Soc. Psychiatry Psychiatr. Epidemiol. 47, 1649\u20131656, https:\/\/doi.org\/10.1007\/s00127-011-0471-8 (2012).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"31191_CR6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jep.2013.02.011","volume":"146","author":"S Kassim","year":"2013","unstructured":"Kassim, S., Croucher, R. & al\u2019Absi, M. Khat dependence syndrome: a cross sectional preliminary evaluation amongst UK-resident Yemeni khat chewers. J. Ethnopharmacol. 146, 835\u2013841, https:\/\/doi.org\/10.1016\/j.jep.2013.02.011 (2013).","journal-title":"J. Ethnopharmacol."},{"key":"31191_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1192\/bjp.170.3.281","volume":"170","author":"P Griffiths","year":"1997","unstructured":"Griffiths, P. et al. A transcultural pattern of drug use: qat (khat) in the UK. Br. J. Psychiatry. 170, 281\u2013284 (1997).","journal-title":"Br. J. Psychiatry."},{"key":"31191_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-698X-13-10","volume":"13","author":"MT Malaju","year":"2013","unstructured":"Malaju, M. T. & Asale, G. A. Association of Khat and alcohol use with HIV infection and age at first sexual initiation among youths visiting HIV testing and counseling centers in Gamo-Gofa Zone, South West Ethiopia. BMC Int. Health Hum. Rights. 13, 10, https:\/\/doi.org\/10.1186\/1472-698X-13-10 (2013).","journal-title":"BMC Int. Health Hum. Rights."},{"key":"31191_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1198","volume":"14","author":"E Gebrehanna","year":"2014","unstructured":"Gebrehanna, E., Berhane, Y. & Worku, A. Khat chewing among Ethiopian University Students- a growing concern. BMC Public Health. 14, 1198, https:\/\/doi.org\/10.1186\/1471-2458-14-1198 (2014).","journal-title":"BMC Public Health."},{"key":"31191_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/pgmj.2010.114603","volume":"87","author":"A Apps","year":"2011","unstructured":"Apps, A., Matloob, S., Dahdal, M. T. & Dubrey, S. W. Khat: an emerging threat to the heart in the UK. Postgrad. Med. J. 87, 387\u2013388, https:\/\/doi.org\/10.1136\/pgmj.2010.114603 (2011).","journal-title":"Postgrad. Med. J."},{"key":"31191_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1600-0773.1992.tb00434.x","volume":"70","author":"P Kalix","year":"1992","unstructured":"Kalix, P. Cathinone, a natural amphetamine. Pharmacol. Toxicol. 70, 77\u201386 (1992).","journal-title":"Pharmacol. Toxicol."},{"key":"31191_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.2042-7158.1986.tb04571.x","volume":"38","author":"R Brenneisen","year":"1986","unstructured":"Brenneisen, R., Geisshusler, S. & Schorno, X. Metabolism of cathinone to (\u2212)-norephedrine and (\u2212)-norpseudoephedrine. J. Pharm. Pharmacol. 38, 298\u2013300 (1986).","journal-title":"J. Pharm. Pharmacol."},{"key":"31191_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0021-9673(92)80270-5","volume":"593","author":"K Mathys","year":"1992","unstructured":"Mathys, K. & Brenneisen, R. Determination of (S)-(\u2212)-cathinone and its metabolites (R,S)-(\u2212)-norephedrine and (R,R)-(\u2212)-norpseudoephedrine in urine by high-performance liquid chromatography with photodiode-array detection. J. Chromatogr. 593, 79\u201385 (1992).","journal-title":"J. Chromatogr."},{"key":"31191_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00008571-200207000-00005","volume":"12","author":"E Aklillu","year":"2002","unstructured":"Aklillu, E., Herrlin, K., Gustafsson, L., Bertilsson, L. & Ingelman-Sundberg, M. Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden. Pharmacogenetics. 12, 375\u2013383, https:\/\/doi.org\/10.1097\/00008571-200207000-00005 (2002).","journal-title":"Pharmacogenetics."},{"key":"31191_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13722-016-0069-2","volume":"12","author":"AR Lifson","year":"2017","unstructured":"Lifson, A. R. et al. Prevalence and factors associated with use of khat: a survey of patients entering HIV treatment programs in Ethiopia. Addict. Sci. Clin. Pract. 12, 3, https:\/\/doi.org\/10.1186\/s13722-016-0069-2 (2017).","journal-title":"Addict. Sci. Clin. Pract."},{"key":"31191_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1600-0447.1999.tb10699.x","volume":"397","author":"A Alem","year":"1999","unstructured":"Alem, A., Kebede, D. & Kullgren, G. The prevalence and socio-demographic correlates of khat chewing in Butajira, Ethiopia. Acta Psychiatr. Scand. Suppl. 397, 84\u201391 (1999).","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"31191_CR17","doi-asserted-by":"publisher","first-page":"e78601","DOI":"10.1371\/journal.pone.0078601","volume":"8","author":"H Kedir","year":"2013","unstructured":"Kedir, H., Berhane, Y. & Worku, A. Khat chewing and restrictive dietary behaviors are associated with anemia among pregnant women in high prevalence rural communities in eastern Ethiopia. PLoS One. 8, e78601, https:\/\/doi.org\/10.1371\/journal.pone.0078601 (2013).","journal-title":"PLoS One."},{"key":"31191_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1080\/13691058.2012.722684","volume":"14","author":"D Berhanu","year":"2012","unstructured":"Berhanu, D., Go, V. F., Ruff, A., Celentano, D. D. & Bishaw, T. Khat use among HIV voluntary counselling and testing centre clients in Ethiopia. Cult Health Sex. 14, 1197\u20131212, https:\/\/doi.org\/10.1080\/13691058.2012.722684 (2012).","journal-title":"Cult Health Sex."},{"key":"31191_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1472-8206.2004.00301.x","volume":"19","author":"AA Izzo","year":"2005","unstructured":"Izzo, A. A. Herb-drug interactions: an overview of the clinical evidence. Fundam. Clin. Pharmacol. 19, 1\u201316, https:\/\/doi.org\/10.1111\/j.1472-8206.2004.00301.x (2005).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"31191_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.0306-5251.2001.01469.x","volume":"52","author":"A Fugh-Berman","year":"2001","unstructured":"Fugh-Berman, A. & Ernst, E. Herb-drug interactions: review and assessment of report reliability. Br. J. Clin. Pharmacol. 52, 587\u2013595 (2001).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"31191_CR21","first-page":"347","volume":"13","author":"S Wanwimolruk","year":"2014","unstructured":"Wanwimolruk, S. & Prachayasittikul, V. Cytochrome P450 enzyme mediated herbal drug interactions (Part 1). EXCLI J. 13, 347\u2013391 (2014).","journal-title":"EXCLI J."},{"key":"31191_CR22","doi-asserted-by":"crossref","unstructured":"Delgoda, R. & Westlake, A. C. Herbal interactions involving cytochrome p450 enzymes: a mini review. Toxicol Rev. 23, 239-249 (2004).","DOI":"10.2165\/00139709-200423040-00004"},{"key":"31191_CR23","doi-asserted-by":"publisher","first-page":"736431","DOI":"10.1155\/2015\/736431","volume":"2015","author":"HJ Cho","year":"2015","unstructured":"Cho, H. J. & Yoon, I. S. Pharmacokinetic interactions of herbs with cytochrome p450 and p-glycoprotein. Evid Based Complement Alternat Med. 2015, 736431, https:\/\/doi.org\/10.1155\/2015\/736431 (2015).","journal-title":"Evid Based Complement Alternat Med."},{"key":"31191_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1872312808666140129123210","volume":"7","author":"C Awortwe","year":"2014","unstructured":"Awortwe, C., Bouic, P. J., Masimirembwa, C. M. & Rosenkranz, B. Inhibition of major drug metabolizing CYPs by common herbal medicines used by HIV\/AIDS patients in Africa\u2013implications for herb-drug interactions. Drug Metab Lett. 7, 83\u201395 (2014).","journal-title":"Drug Metab Lett."},{"key":"31191_CR25","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.4268\/cjcmm20162410","volume":"41","author":"X Du","year":"2016","unstructured":"Du, X., He, X., Huang, Y. H. & Li, Z. Q. [Progress on studies of impact on CYP450 enzymes activity of traditional Chinese medicine by Cocktail probe substrates approach]. Zhongguo Zhong Yao Za Zhi. 41, 4541\u20134549, https:\/\/doi.org\/10.4268\/cjcmm20162410 (2016).","journal-title":"Zhongguo Zhong Yao Za Zhi."},{"key":"31191_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000443178","volume":"97","author":"YT Zhang","year":"2016","unstructured":"Zhang, Y. T. et al. Effect of Evodiamine on CYP Enzymes in Rats by a Cocktail Method. Pharmacology. 97, 218\u2013223, https:\/\/doi.org\/10.1159\/000443178 (2016).","journal-title":"Pharmacology."},{"key":"31191_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jac\/39.4.523","volume":"39","author":"OA Attef","year":"1997","unstructured":"Attef, O. A., Ali, A. A. & Ali, H. M. Effect of Khat chewing on the bioavailability of ampicillin and amoxycillin. J. Antimicrob. Chemother. 39, 523\u2013525 (1997).","journal-title":"J. Antimicrob. Chemother."},{"key":"31191_CR28","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.18295\/squmj.2016.16.02.008","volume":"16","author":"FH Issa","year":"2016","unstructured":"Issa, F. H., Al-Habori, M. & Chance, M. L. Effect of Khat (Catha edulis) Use on the Bioavailability, Plasma Levels and Antimalarial Activity of Chloroquine. Sultan Qaboos Univ Med J. 16, e182\u2013188, https:\/\/doi.org\/10.18295\/squmj.2016.16.02.008 (2016).","journal-title":"Sultan Qaboos Univ Med J."},{"key":"31191_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/JCP.0000000000000413","volume":"35","author":"W Bedada","year":"2015","unstructured":"Bedada, W. et al. The Psychostimulant Khat (Catha edulis) Inhibits CYP2D6 Enzyme Activity in Humans. J. Clin. Psychopharmacol. 35, 694\u2013699, https:\/\/doi.org\/10.1097\/jcp.0000000000000413 (2015).","journal-title":"J. Clin. Psychopharmacol."},{"key":"31191_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2125.2003.01834.x","volume":"56","author":"SW Toennes","year":"2003","unstructured":"Toennes, S. W., Harder, S., Schramm, M., Niess, C. & Kauert, G. F. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br. J. Clin. Pharmacol. 56, 125\u2013130 (2003).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"31191_CR31","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/clinchem\/48.10.1715","volume":"48","author":"SW Toennes","year":"2002","unstructured":"Toennes, S. W. & Kauert, G. F. Excretion and detection of cathinone, cathine, and phenylpropanolamine in urine after kath chewing. Clin. Chem. 48, 1715\u20131719 (2002).","journal-title":"Clin. Chem."},{"key":"31191_CR32","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/add.13421","volume":"111","author":"SW Duresso","year":"2016","unstructured":"Duresso, S. W., Matthews, A. J., Ferguson, S. G. & Bruno, R. Is khat use disorder a valid diagnostic entity? Addiction. 111, 1666\u20131676, https:\/\/doi.org\/10.1111\/add.13421 (2016).","journal-title":"Addiction."},{"key":"31191_CR33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-3565(25)20152-5","volume":"278","author":"E Aklillu","year":"1996","unstructured":"Aklillu, E. et al. Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J. Pharmacol. Exp. Ther. 278, 441\u2013446 (1996).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"31191_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1089\/omi.2013.0140","volume":"18","author":"E Aklillu","year":"2014","unstructured":"Aklillu, E. et al. High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population. OMICS. 18, 446\u2013453, https:\/\/doi.org\/10.1089\/omi.2013.0140 (2014).","journal-title":"OMICS."},{"key":"31191_CR35","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1089\/omi.2016.0119","volume":"20","author":"E Aklillu","year":"2016","unstructured":"Aklillu, E. et al. SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine. OMICS. 20, 538\u2013545, https:\/\/doi.org\/10.1089\/omi.2016.0119 (2016).","journal-title":"OMICS."},{"key":"31191_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/tpj.2010.16","volume":"11","author":"E Gebeyehu","year":"2011","unstructured":"Gebeyehu, E. et al. Sex and CYP3A5 genotype influence total CYP3A activity: high CYP3A activity and a unique distribution of CYP3A5 variant alleles in Ethiopians. Pharmacogenomics J. 11, 130\u2013137, https:\/\/doi.org\/10.1038\/tpj.2010.16 (2011).","journal-title":"Pharmacogenomics J."},{"key":"31191_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/omi.2015.0159","volume":"19","author":"FH Hatta","year":"2015","unstructured":"Hatta, F. H. & Aklillu, E. P450 (Cytochrome) Oxidoreductase Gene (POR) Common Variant (POR*28) Significantly Alters CYP2C9 Activity in Swedish, But Not in Korean Healthy Subjects. Omics. 19, 777\u2013781, https:\/\/doi.org\/10.1089\/omi.2015.0159 (2015).","journal-title":"Omics."},{"key":"31191_CR38","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1517\/17425255.2015.1111871","volume":"11","author":"C Cespedes-Garro","year":"2015","unstructured":"Cespedes-Garro, C. et al. Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes. Expert Opin Drug Metab Toxicol. 11, 1893\u20131905, https:\/\/doi.org\/10.1517\/17425255.2015.1111871 (2015).","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"31191_CR39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1089\/omi.2015.0022","volume":"19","author":"FH Hatta","year":"2015","unstructured":"Hatta, F. H. et al. Differences in CYP2C9 Genotype and Enzyme Activity Between Swedes and Koreans of Relevance for Personalized Medicine: Role of Ethnicity, Genotype, Smoking, Age, and Sex. OMICS. 19, 346\u2013353, https:\/\/doi.org\/10.1089\/omi.2015.0022 (2015).","journal-title":"OMICS."},{"key":"31191_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00127-006-0043-5","volume":"41","author":"K Bhui","year":"2006","unstructured":"Bhui, K. et al. Mental disorders among Somali refugees: developing culturally appropriate measures and assessing socio-cultural risk factors. Soc. Psychiatry Psychiatr. Epidemiol. 41, 400\u2013408, https:\/\/doi.org\/10.1007\/s00127-006-0043-5 (2006).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"31191_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fpubh.2014.00071","volume":"2","author":"M Widmann","year":"2014","unstructured":"Widmann, M. et al. Khat Use, PTSD and Psychotic Symptoms among Somali Refugees in Nairobi - A Pilot Study. Front Public Health. 2, 71, https:\/\/doi.org\/10.3389\/fpubh.2014.00071 (2014).","journal-title":"Front Public Health."},{"key":"31191_CR42","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jep.2010.05.033","volume":"132","author":"R Hoffman","year":"2010","unstructured":"Hoffman, R. & Al\u2019Absi, M. Khat use and neurobehavioral functions: suggestions for future studies. J. Ethnopharmacol. 132, 554\u2013563, https:\/\/doi.org\/10.1016\/j.jep.2010.05.033 (2010).","journal-title":"J. Ethnopharmacol."},{"key":"31191_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00127-010-0216-0","volume":"46","author":"J Kroll","year":"2011","unstructured":"Kroll, J., Yusuf, A. I. & Fujiwara, K. Psychoses, PTSD, and depression in Somali refugees in Minnesota. Soc. Psychiatry Psychiatr. Epidemiol. 46, 481\u2013493, https:\/\/doi.org\/10.1007\/s00127-010-0216-0 (2011).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"31191_CR44","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.pnpbp.2007.12.033","volume":"32","author":"AM Feyissa","year":"2008","unstructured":"Feyissa, A. M. & Kelly, J. P. A review of the neuropharmacological properties of khat. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32, 1147\u20131166, https:\/\/doi.org\/10.1016\/j.pnpbp.2007.12.033 (2008).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"31191_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.phrs.2012.10.009","volume":"67","author":"A Haduch","year":"2013","unstructured":"Haduch, A., Bromek, E., Sadakierska-Chudy, A., Wojcikowski, J. & Daniel, W. A. The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study. Pharmacol. Res. 67, 53\u201359, https:\/\/doi.org\/10.1016\/j.phrs.2012.10.009 (2013).","journal-title":"Pharmacol. Res."},{"key":"31191_CR46","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3109\/00498254.2013.791410","volume":"43","author":"J Cheng","year":"2013","unstructured":"Cheng, J. et al. Potential role of CYP2D6 in the central nervous system. Xenobiotica. 43, 973\u2013984, https:\/\/doi.org\/10.3109\/00498254.2013.791410 (2013).","journal-title":"Xenobiotica."},{"key":"31191_CR47","first-page":"329","volume":"77","author":"NB Patel","year":"2000","unstructured":"Patel, N. B. Mechanism of action of cathinone: the active ingredient of khat (Catha edulis). East Afr. Med. J. 77, 329\u2013332 (2000).","journal-title":"East Afr. Med. J."},{"key":"31191_CR48","doi-asserted-by":"publisher","first-page":"e20602","DOI":"10.1371\/journal.pone.0020602","volume":"6","author":"LS Colzato","year":"2011","unstructured":"Colzato, L. S., Ruiz, M. J., van den Wildenberg, W. P. & Hommel, B. Khat use is associated with impaired working memory and cognitive flexibility. PLoS One. 6, e20602, https:\/\/doi.org\/10.1371\/journal.pone.0020602 (2011).","journal-title":"PLoS One."},{"key":"31191_CR49","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/FPC.0b013e3282f01aa3","volume":"17","author":"E Aklillu","year":"2007","unstructured":"Aklillu, E. et al. CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine. Pharmacogenet. Genomics. 17, 989\u2013993, https:\/\/doi.org\/10.1097\/FPC.0b013e3282f01aa3 (2007).","journal-title":"Pharmacogenet. Genomics."},{"key":"31191_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-6-234","volume":"6","author":"N Tadesse","year":"2013","unstructured":"Tadesse, N., Awoke Ayele, T., Birhanu Mengesha, Z. & Addis Alene, K. High prevalence of HIV\/AIDS risky sexual behaviors among street youth in Gondar town: a community based cross sectional study. BMC Res. Notes. 6, 234, https:\/\/doi.org\/10.1186\/1756-0500-6-234 (2013).","journal-title":"BMC Res. Notes."},{"key":"31191_CR51","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJMc1301936","volume":"369","author":"JW Bennett","year":"2013","unstructured":"Bennett, J. W. et al. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N. Engl. J. Med. 369, 1381\u20131382, https:\/\/doi.org\/10.1056\/NEJMc1301936 (2013).","journal-title":"N. Engl. J. Med."},{"key":"31191_CR52","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1124\/dmd.31.6.748","volume":"31","author":"D Projean","year":"2003","unstructured":"Projean, D. et al. In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab. Dispos. 31, 748\u2013754 (2003).","journal-title":"Drug Metab. Dispos."},{"key":"31191_CR53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1046\/j.1365-2125.1996.30713.x","volume":"41","author":"CM Masimirembwa","year":"1996","unstructured":"Masimirembwa, C. M., Gustafsson, L. L., Dahl, M. L., Abdi, Y. A. & Hasler, J. A. Lack of effect of chloroquine on the debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19) hydroxylation phenotypes. Br J Clin Pharmacol. 41, 344\u2013346 (1996).","journal-title":"Br J Clin Pharmacol."},{"key":"31191_CR54","doi-asserted-by":"publisher","first-page":"e0130460","DOI":"10.1371\/journal.pone.0130460","volume":"10","author":"D Haile","year":"2015","unstructured":"Haile, D. & Lakew, Y. Khat Chewing Practice and Associated Factors among Adults in Ethiopia: Further Analysis Using the 2011 Demographic and Health Survey. PLoS One. 10, e0130460, https:\/\/doi.org\/10.1371\/journal.pone.0130460 (2015).","journal-title":"PLoS One."},{"key":"31191_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/omi.2015.0131","volume":"20","author":"F de Andres","year":"2016","unstructured":"de Andres, F. et al. Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach. OMICS. 20, 88\u201396, https:\/\/doi.org\/10.1089\/omi.2015.0131 (2016).","journal-title":"OMICS."},{"key":"31191_CR56","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4155\/bio.14.20","volume":"6","author":"F de Andres","year":"2014","unstructured":"de Andres, F., Sosa-Macias, M. & Llerena, A. A rapid and simple LC-MS\/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity. Bioanalysis. 6, 683\u2013696, https:\/\/doi.org\/10.4155\/bio.14.20 (2014).","journal-title":"Bioanalysis."},{"key":"31191_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jchromb.2013.04.043","volume":"930","author":"Y Al-Saffar","year":"2013","unstructured":"Al-Saffar, Y., Stephanson, N. N. & Beck, O. Multicomponent LC-MS\/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 930, 112\u2013120, https:\/\/doi.org\/10.1016\/j.jchromb.2013.04.043 (2013).","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"31191_CR58","doi-asserted-by":"publisher","first-page":"e86919","DOI":"10.1371\/journal.pone.0086919","volume":"9","author":"JK Mukonzo","year":"2014","unstructured":"Mukonzo, J. K. et al. Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes. PLoS One. 9, e86919, https:\/\/doi.org\/10.1371\/journal.pone.0086919 (2014).","journal-title":"PLoS One."},{"key":"31191_CR59","doi-asserted-by":"publisher","first-page":"e40180","DOI":"10.1371\/journal.pone.0040180","volume":"7","author":"S Mugusi","year":"2012","unstructured":"Mugusi, S. et al. Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania. PLoS One. 7, e40180, https:\/\/doi.org\/10.1371\/journal.pone.0040180 (2012).","journal-title":"PLoS One."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31191-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T12:20:17Z","timestamp":1751804417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31191-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31191"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31191-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]},"assertion":[{"value":"17 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12726"}}